Paper21622860
Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.
Long HM and 7 others. J Immunol, 2011. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. Papers, record 21622860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21622860
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4-Positive T-Lymphocytes | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Cytotoxicity Tests, Immunologic | Major topic |
| Gene Expression Regulation, Viral | Major topic |
| Herpesvirus 4, Human | Major topic |
| Virus Replication | Major topic |
| Antigens, Viral | |
| Cells, Cultured | |
| Clone Cells | |
| Epitope Mapping | |
| Epitopes, T-Lymphocyte | |
| Humans | |
| Immediate-Early Proteins | |
| Interferon-gamma | |
| Phosphoproteins | |
| Trans-Activators |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0901755-E02/1 | Medical Research Council | United Kingdom | PubMed | |
| G0901755 | Medical Research Council | United Kingdom | PubMed | |
| G0901755-E02/1 | PHS HHS | United States | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8053055 | Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. | Transplantation | 1994 | https://conductscience.org/library/papers/8053055 | PubMed |
| 2 | 11507210 | Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses. | J Virol | 2001 | https://conductscience.org/library/papers/11507210 | PubMed |
| 3 | 12975456 | Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. | J Exp Med | 2003 | https://conductscience.org/library/papers/12975456 | PubMed |
| 4 | 12134023 | The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules. | J Virol | 2002 | https://conductscience.org/library/papers/12134023 | PubMed |
| 5 | 19605492 | Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection. | J Virol | 2009 | https://conductscience.org/library/papers/19605492 | PubMed |
| 6 | 16147978 | Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. | J Exp Med | 2005 | https://conductscience.org/library/papers/16147978 | PubMed |
| 7 | 17378764 | Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. | Annu Rev Immunol | 2007 | https://conductscience.org/library/papers/17378764 | PubMed |
| 8 | 12165547 | Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope. | J Immunol | 2002 | https://conductscience.org/library/papers/12165547 | PubMed |
| 9 | 15310471 | The immune response to Epstein-Barr virus. | Microbes Infect | 2004 | https://conductscience.org/library/papers/15310471 | PubMed |
| 10 | 20385879 | Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors. | J Immunol | 2010 | https://conductscience.org/library/papers/20385879 | PubMed |
| 11 | 15307182 | Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells. | Eur J Immunol | 2004 | https://conductscience.org/library/papers/15307182 | PubMed |
| 12 | 15919916 | Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative epstein-barr virus. | J Virol | 2005 | https://conductscience.org/library/papers/15919916 | PubMed |
| 13 | 16549597 | Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. | J Exp Med | 2006 | https://conductscience.org/library/papers/16549597 | PubMed |
| 14 | 20133861 | Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133861 | PubMed |
| 15 | 1710291 | Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones. | J Virol | 1991 | https://conductscience.org/library/papers/1710291 | PubMed |
| 16 | 19439479 | Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. | J Virol | 2009 | https://conductscience.org/library/papers/19439479 | PubMed |
| 17 | 10856251 | The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. | EMBO J | 2000 | https://conductscience.org/library/papers/10856251 | PubMed |
| 18 | 15827162 | Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity. | J Virol | 2005 | https://conductscience.org/library/papers/15827162 | PubMed |
| 19 | 15795275 | CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. | J Virol | 2005 | https://conductscience.org/library/papers/15795275 | PubMed |
| 20 | 8553567 | Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. | Virology | 1995 | https://conductscience.org/library/papers/8553567 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41034205 | Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19. | Nat Commun | 2025 | https://conductscience.org/library/papers/41034205 | PubMed |
| 39776919 | EBV-specific T-cell immunity: relevance for multiple sclerosis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39776919 | PubMed |
| 39505801 | Research landmarks on the 60th anniversary of Epstein-Barr virus. | Sci China Life Sci | 2025 | https://conductscience.org/library/papers/39505801 | PubMed |
| 39346922 | Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice. | Front Immunol | 2024 | https://conductscience.org/library/papers/39346922 | PubMed |
| 38179040 | Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. | Front Immunol | 2023 | https://conductscience.org/library/papers/38179040 | PubMed |
| 37865406 | Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised children. | BMJ Open | 2023 | https://conductscience.org/library/papers/37865406 | PubMed |
| 36456735 | Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition. | Nat Immunol | 2022 | https://conductscience.org/library/papers/36456735 | PubMed |
| 36077655 | Concomitant Cytotoxic Effector Differentiation of CD4+ and CD8+ T Cells in Response to EBV-Infected B Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077655 | PubMed |
| 35686929 | Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35686929 | PubMed |
| 34882759 | Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34882759 | PubMed |
| 34668039 | CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes. | Cancer Immunol Immunother | 2022 | https://conductscience.org/library/papers/34668039 | PubMed |
| 34638238 | Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638238 | PubMed |
| 34068598 | Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34068598 | PubMed |
| 33901176 | The dominantly expressed class II molecule from a resistant MHC haplotype presents only a few Marek's disease virus peptides by using an unprecedented binding motif. | PLoS Biol | 2021 | https://conductscience.org/library/papers/33901176 | PubMed |
| 33662046 | PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33662046 | PubMed |
| 33658348 | T cell epitope screening of Epstein-Barr virus fusion protein gB. | J Virol | 2021 | https://conductscience.org/library/papers/33658348 | PubMed |
| 33102204 | Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals. | Front Oncol | 2020 | https://conductscience.org/library/papers/33102204 | PubMed |
| 32461311 | The Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4+ T Cells. | J Virol | 2020 | https://conductscience.org/library/papers/32461311 | PubMed |
| 31620125 | The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog. | Front Immunol | 2019 | https://conductscience.org/library/papers/31620125 | PubMed |
| 31308093 | Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. | J Immunol | 2019 | https://conductscience.org/library/papers/31308093 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21622860
GET https://conductscience.org/api/papers/v1/21622860/references?page=2